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In the American epidemic of diabetes and obesity, doctors diagnose an additional 3,700 
American children with type-2 diabetes every year. In addition, the most common form of liver 
disease in children, potentially severe, non-alcoholic fatty liver disease, is also increasing. If your 
child has diabetes, his or her chances of getting non-alcoholic fatty liver disease increase 
significantly. What is not known is how the two are connected; nor is it known if the liver 
disease impairs the liver’s ability to make 25(OH)D in these children, thus rendering them even 
more D deficient than sun avoidance would otherwise leave them. 
In a brilliantly designed experiment, Dr. Benjamin Nwosu and colleagues from the University of 
Massachusetts Medical School compared young teenagers with the autoimmune disease, type I 
diabetes, with children suffering from the obesity-driven type II diabetes, measuring 25(OH)D, 
liver function, and diabetic severity in all the children. 
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They discovered that the type II kids had much lower vitamin D levels than the type I kids. In 
fact, almost three times as many type II children were very deficient (<15 ng/ml) compared to 
type I, and the type II kids were more likely to have liver disease. Furthermore, in type II 
diabetes, low 25(OH)D was linearly related to both an elevated liver function test (ALT) and 
with elevated hemoglobin A1C (a measure of long-term blood glucose). The higher the 
25(OH)D, the better both those tests; neither test showed evidence of a threshold or upper 
limit cutoff for the effectiveness of vitamin D. 
The authors conclude, 
“Taken together, our data suggest that there is an association between liver 
dysfunction, vitamin D deficiency and impaired glycemic control in type 2 
diabetes.” 
That is, the liver of children with type II diabetes may not be able to make as much 25(OH)D as 
other kids because their liver is damaged, which in turn, may make both their diabetes and liver 
disease worse, a vicious circle. 
Until several years ago, 25(OH)D itself was available as a prescription drug. That would solve 
this problem in these children if higher doses of vitamin D did not. Now, if a drug company 
would just start making 25(OH)D again. It is a natural product; it occurs naturally in the human 
body so perhaps a vitamin company could start making it, like Bio Tech Pharmacal? 
 
